Thyroid hormones, serotonin and mood: Of synergy and significance in the adult brain

Molecular Psychiatry

Volumn 7, Issue 2, 2002, Pages 140-156

  Bauer, M ^a   Heinz, A ^b   Whybrow, P C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

5 HT receptor; Adult brain; Affective disorders; Depression; Mood modulation; Serotonin system; T3; T4; Thyroid system

Indexed keywords

AFFECT; ANIMALS; BRAIN; DRUG SYNERGISM; HUMANS; MOOD DISORDERS; SEROTONIN; THYROID HORMONES;

CARBIMAZOLE; CATECHOLAMINE; CLOMIPRAMINE; DESIPRAMINE; LIOTHYRONINE; PROPYLTHIOURACIL; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; THIAMAZOLE; THYROID HORMONE; THYROXINE;

AFFECTIVE NEUROSIS; AUTOREGULATION; BRAIN CORTEX; HORMONAL REGULATION; HUMAN; HYPOTHYROIDISM; INHIBITION KINETICS; MONOAMINE RELEASE; MOOD; MOUSE; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REVIEW; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; TISSUE DISTRIBUTION;

EID: 85047700265     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000963     Document Type: Review

References (111)

1. Behavioral and psychiatric aspects of thyrotoxicosis
2. Behavioral and psychiatric aspects of hypothyroidism
3. Thyroid hormone, neural tissue and mood modulation
4. Rapid cycling bipolar affective disorders. II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study
5. Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: An open clinical trial
6. Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders
7. Does thyroid supplementation accelerate antidepressant response? A review and meta-analysis of the literature
8. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis
9. Treatment of refractory depression with high-dose thyroxine
10. The role of thyroid hormones in prenatal and neonatal neurological development - Current perspectives
11. Thyroid hormones and brain development
12. Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment
13. The cerebral circulation and metabolism in hyperthyroidism and myxedema
14. Cerebral-cortex perfusion-rates in myxoedema
15. Molecular actions of thyroid hormone
16. Thyroid hormones and the treatment of depression: An examination of basic hormonal actions in the mature mammalian brain
17. Nuclear triiodothyronine receptor sites in brain: Probable identity with hepatic receptors and regional distribution
18. 3 receptors in rat brain and evidence for preferential localization in neurons
19. The deiodinase family of selenoproteins
20. Concentrations of thyroxine and 3, 5, 3′-triiodothyronine at 34 different sites in euthyroid rats as determined by an isotopic equilibrium technique
21. Dibutyryl cAMP induction of type II 5′deiodinase activity in rat brain astrocytes in culture
22. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system
23. Current advances and trends in the treatment of depression
24. Recent studies on norepinephrine systems in mood disorders
25. The serotonin hypotheses of major depression
26. Adrenal, medullary, and thyroid relationships
27. A hypotheses of thyroid-catecholamine-receptor interaction
28. Immunohistochemical mapping of brain triiodothyronine reveals prominent localization in central noradrenergic systems
29. Evidence that 3, 3′, 5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport
30. Structure and function of the brain serotonin system
31. The biochemistry of affective disorders
32. Serotonin depression' - A biochemical subgroup within the affective disorders?
33. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients
34. Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression
35. Serotonin function and the mechanisms of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan
36. Reduced serotonin transporters in alcoholism
37. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2-β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
38. Effect of neonatal hypothyroidism on the serotonin system of the rat brain
39. Brain biogenic amines and altered thyroid function
40. Thyroid hormone control of serotonin in developing rat brain
41. Effects of thyroid state on serotonin, 5-hydroxyindoleacetic acid and substance P contents in discrete brain nuclei of adult rats
42. Hypothyroidism increases serotonin turnover and sympathetic activity in the adult rat
43. Streptozotocin-induced decreases in serotonin turnover are prevented by thyroidectomy
44. Hypothyroid-induced changes in autonomic control have a central serotonergic component
45. Bulbospinal serotonergic activity during changes in thyroid status
46. Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain
47. Effect of L-thyroxine and carbimazole on brain biogenic amines and amino acids in rats
48. Thyroid state and brain monoamine metabolism
49. Effects of different thyroid states on 5-HT1A receptor in adult rat brain
50. Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: An autoradiographic analysis
51. Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain
52. The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain
53. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain
54. 3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock
55. Brain monoamine synthesis and receptor sensitivity after single or repeated administration of thyroxine
56. Hyperthyroidism: Specifically increased response to central NA-(alpha-) receptor stimulation and generally increased monoamine turnover in brain
57. Triiodothyronine increases desipramine by changing the concentrations of monoamines, in the brain of rats given imipramine
58. Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain
59. Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: Relationship to serotonin autoreceptor activity
60. 3) administration to rats on central 5-HT and dopamine-mediated behavioural responses and related brain biochemistry
61. The influence of L-triiodothyronine on the action of desipramine on beta and serotonin 2A receptor, monoamines in rat brain
62. Reduced prolactin release during immobolization stress in thyrotoxic rats: Role of the central serotonergic system
63. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
64. L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: A pilot study
65. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression
66. Pindolol treatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men
67. Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism
68. Biogenic amines and thyrotoxicosis
69. Thyroid axis activity and serotonin function in major depressive episode
70. Peripheral indices of central serotonin function in humans
71. Hormonal probes of central serotonergic activity? Do they really exist?
72. Differential effects of clomipramine given locally or systematically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex: An in vivo microdialysis study
73. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
74. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
75. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study
76. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation
77. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects
78. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects
79. Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function
80. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients
81. 5-HT neuroendocrine function in major depression: Prolactin and cortisol responses to d-fenflufamine
82. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder
83. Clomipramine enhances the cortisol response to 5-HTP: Implications for the therapeutic role of 5-HT2 receptors
84. D-fenfluramine-induced prolactin and cortisol release in major depression: Response to treatment
85. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms
86. Serotonin function in human subjects: Intercorrelations among central 5-HT indices and aggressiveness
87. Effect of pindolol on hormone secretion and body temperature: Partial agonist effects
88. 5-HT2 receptor changes in major depression
89. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment
90. Abundance of the alpha-subunits of Gi1, Gi2 and Go in synaptosomal membranes from several regions of the rat brain is increased in hypothyroidism
91. Treatment with triiodothyronine decreases the abundance of the alpha-subunits of Gi1 and Gi2 in the cerebral cortex
92. Inhibition of adenylate cyclase in rat brain synaptosomal membranes by GTP and phenylisopropyl-adenosine is enhanced in hypothyroidism
93. Hypothyroidism inhibits the formation of inositol phosphate in response to carbachol in the striatum of adult rat
94. The molecular basis of thyroid hormone action
95. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: Evidence for tissue-specific modulation of receptor function
96. The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production
97. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1
98. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation
99. An unliganded thyroid hormone receptor causes severe neurological dysfunction
100. Thyroid hormone metabolism and action in the brain and pituitary
101. Influence of thyroid hormone on brain gene expression
102. Adult rat brain is sensitive to thyroid hormone. Regulation of RC3/neurogranin mRNA
103. Metabolic fuel and amino acid transport into the brain in experimental hypothyroidism
104. Thyroid hormone action on glucose transporter activity in astrocytes
105. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization
106. Thyroid hormone regulates (TRH) biosynthesis in the paraventricular nucleus of the rat hypothalamus
107. Response of hypothalamic peptide mRNAs to thyroidectomy
108. Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain
109. Expression of neurotrophins and the trk family of neurotrophin receptors in normal and hypothyroid rat brain
110. Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain, and cultured cells
111. 2A receptor-mediated regulation of hippocampal BDNF mRNA expression